These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 25343291

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Studies on the cytochrome P450 (CYP)-mediated metabolic properties of miocamycin: evaluation of the possibility of a metabolic intermediate complex formation with CYP, and identification of the human CYP isoforms.
    Kasahara M, Suzuki H, Komiya I.
    Drug Metab Dispos; 2000 Apr; 28(4):409-17. PubMed ID: 10725309
    [Abstract] [Full Text] [Related]

  • 23. Metabolism of dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylene dioxybiphenyl-2,2'-dicarboxylate (DDB) by human liver microsomes: characterization of metabolic pathways and of cytochrome P450 isoforms involved.
    Baek MS, Kim JY, Myung SW, Yim YH, Jeong JH, Kim DH.
    Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):381-8. PubMed ID: 11259320
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. In vitro identification of cytochrome P450 isoforms responsible for the metabolism of 1-hydroxyl-2,3,5-trimethoxy-xanthone purified from Halenia elliptica D. Don.
    Feng R, Zhou X, Tan XS, Or PM, Hu T, Fu J, Ma JY, Huang M, He CY, Shi JG, Che CT, Yeung JH, Wang Y.
    Chem Biol Interact; 2014 Mar 05; 210():12-9. PubMed ID: 24380714
    [Abstract] [Full Text] [Related]

  • 27. Metabolic kinetics of pseudoracemic propranolol in human liver microsomes. Enantioselectivity and quinidine inhibition.
    Marathe PH, Shen DD, Nelson WL.
    Drug Metab Dispos; 1994 Mar 05; 22(2):237-47. PubMed ID: 8013280
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity.
    Faucette SR, Hawke RL, Lecluyse EL, Shord SS, Yan B, Laethem RM, Lindley CM.
    Drug Metab Dispos; 2000 Oct 05; 28(10):1222-30. PubMed ID: 10997944
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. In vitro identification of metabolic pathways and cytochrome P450 enzymes involved in the metabolism of etoperidone.
    Yan Z, Caldwell GW, Wu WN, McKown LA, Rafferty B, Jones W, Masucci JA.
    Xenobiotica; 2002 Nov 05; 32(11):949-62. PubMed ID: 12487725
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. In vitro and in vivo human metabolism and pharmacokinetics of S- and R-praziquantel.
    Kapungu NN, Li X, Nhachi C, Masimirembwa C, Thelingwani RS.
    Pharmacol Res Perspect; 2020 Aug 05; 8(4):e00618. PubMed ID: 32700798
    [Abstract] [Full Text] [Related]

  • 40. Stereoselective oxidation metabolism of 20(S)-protopanaxatriol in human liver microsomes and in rats.
    Wang W, Ni Y, Wang L, Che X, Liu W, Meng Q.
    Xenobiotica; 2015 May 05; 45(5):385-95. PubMed ID: 25430797
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.